Skip to content

Gilbert to present at Respiratory Innovation Summit at ATS 2026!

Gilbert is proud to have been selected to be featured as a POSTER at the Respiratory Innovation Summit (RIS) in Orlando, Florida. Hosted by the American Thoracic Society (ATS), the annual RIS attracts over 300 global leaders representing all facets of the respiratory industry. If you’re attending hashtag#RIS2026 come meet our Chief Commercial Officer Scott Fleming at our Poster #140 for his presentation: Next-generation Inhaled Therapies Require Next-generation Delivery Solutions and Q&A. The respiratory field is evolving rapidly, and conversations like these are essential to shaping the next generation of inhaled therapeutics together.

Let’s redefine inhaled therapies for patients together! To learn more, please contact us at info@gilbert.eu or reach out directly to our CCO Scott Fleming.

Gilbert is developing the next generation of soft mist inhalers based on a proprietary electrospray (Electro Hydrodynamic Atomization or EHDA) technology to redefine treatment for patients with the next generation of inhaled therapies. Gilbert’s breath actuated smart precision inhaler creates a monodispersed soft mist aerosol, with a customizable droplet size enabling more precise targeting of drugs to desired regions of the lungs, which has the potential to improve the efficacy and safety of treatments. Electrospray enables gentle, efficient delivery of both small and large molecule therapies in both solution and suspension formulations.

Visit us at Gilbert | Redefining treatment for lung patients, follow us on Linkedin or contact us at info@gilbert.eu to learn if electrospray is suitable for your application.

Other posts

Let’s stay in touch!

Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.